| Year |
Citation |
Score |
| 2023 |
Sato M, Neufeld EB, Playford MP, Lei Y, Sorokin AV, Aponte AM, Freeman LA, Gordon SM, Dey AK, Jeiran K, Hamasaki M, Sampson ML, Shamburek RD, Tang J, Chen MY, ... ... Dullaart RP, et al. Cell-free high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease. The Journal of Clinical Investigation. PMID 37471145 DOI: 10.1172/JCI165370 |
0.401 |
|
| 2016 |
Annema W, Willemsen HM, de Boer JF, Dikkers A, van der Giet M, Nieuwland W, Muller Kobold AC, van Pelt LJ, Slart RH, van der Horst IC, Dullaart RP, Tio RA, Tietge UJ. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels. Journal of Clinical Lipidology. 10: 1318-1328. PMID 27919348 DOI: 10.1016/j.jacl.2016.08.003 |
0.41 |
|
| 2016 |
Annema W, Dikkers A, de Boer JF, van Greevenbroek MM, van der Kallen CJ, Schalkwijk CG, Stehouwer CD, Dullaart RP, Tietge UJ. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study. Scientific Reports. 6: 27367. PMID 27270665 DOI: 10.1038/srep27367 |
0.416 |
|
| 2015 |
van Tienhoven-Wind LJ, Perton FG, Dullaart RP. Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus. Clinical Biochemistry. 49: 41-6. PMID 26320015 DOI: 10.1016/j.clinbiochem.2015.08.024 |
0.412 |
|
| 2015 |
Gruppen EG, Connelly MA, Otvos JD, Bakker SJ, Dullaart RP. A novel protein glycan biomarker and LCAT activity in metabolic syndrome. European Journal of Clinical Investigation. 45: 850-9. PMID 26081900 DOI: 10.1111/Eci.12481 |
0.341 |
|
| 2015 |
Koopal C, Retterstøl K, Sjouke B, Hovingh GK, Ros E, de Graaf J, Dullaart RP, Bertolini S, Visseren FL. Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study. Atherosclerosis. 240: 90-7. PMID 25768710 DOI: 10.1016/j.atherosclerosis.2015.02.046 |
0.395 |
|
| 2015 |
van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and novel cardiometabolic biomarkers. Nutrients. 7: 1352-77. PMID 25690422 DOI: 10.3390/nu7021352 |
0.353 |
|
| 2015 |
van Tienhoven-Wind L, Dullaart RP. Low normal thyroid function as a determinant of increased large very low density lipoprotein particles. Clinical Biochemistry. 48: 489-94. PMID 25666190 DOI: 10.1016/j.clinbiochem.2015.01.015 |
0.384 |
|
| 2015 |
Dullaart RP, de Vries R, Kwakernaak AJ, Perton F, Dallinga-Thie GM. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes. European Journal of Clinical Investigation. 45: 36-44. PMID 25402623 DOI: 10.1111/eci.12377 |
0.531 |
|
| 2014 |
Abbasi A, Dallinga-Thie GM, Dullaart RP. Phospholipid transfer protein activity and incident type 2 diabetes mellitus. Clinica Chimica Acta; International Journal of Clinical Chemistry. 439: 38-41. PMID 25304745 DOI: 10.1016/j.cca.2014.09.035 |
0.348 |
|
| 2014 |
Dullaart RP, de Vries R, Lefrandt JD. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus. Clinical Biochemistry. 47: 170-5. PMID 25149194 DOI: 10.1016/j.clinbiochem.2014.08.008 |
0.386 |
|
| 2014 |
Kwakernaak AJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins. Clinical Biochemistry. 47: 679-82. PMID 24680982 DOI: 10.1016/j.clinbiochem.2014.03.008 |
0.39 |
|
| 2014 |
Triolo M, Annema W, de Boer JF, Tietge UJ, Dullaart RP. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. European Journal of Clinical Investigation. 44: 240-8. PMID 24325778 DOI: 10.1111/eci.12226 |
0.468 |
|
| 2013 |
Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC, Feskens EJ, van Beek AP, van der Klauw MM, Wolffenbuttel BH. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. Bmc Medicine. 11: 195. PMID 24228807 DOI: 10.1186/1741-7015-11-195 |
0.351 |
|
| 2013 |
Triolo M, Annema W, Dullaart RP, Tietge UJ. Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research. Biomarkers in Medicine. 7: 457-72. PMID 23734809 DOI: 10.2217/bmm.13.35 |
0.407 |
|
| 2013 |
Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Hillege HL, Stolk RP, Navis G, Bakker SJ, Dullaart RP. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. The Journal of Clinical Endocrinology and Metabolism. 98: E1352-9. PMID 23690306 DOI: 10.1210/jc.2013-1680 |
0.469 |
|
| 2013 |
Triolo M, Kwakernaak AJ, Perton FG, de Vries R, Dallinga-Thie GM, Dullaart RP. Low normal thyroid function enhances plasma cholesteryl ester transfer in Type 2 diabetes mellitus. Atherosclerosis. 228: 466-71. PMID 23591416 DOI: 10.1016/j.atherosclerosis.2013.03.009 |
0.409 |
|
| 2013 |
Dullaart RP, de Boer JF, Annema W, Tietge UJ. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects. Obesity (Silver Spring, Md.). 21: 361-6. PMID 23404653 DOI: 10.1002/oby.20058 |
0.315 |
|
| 2013 |
de Vries R, Dikkeschei BD, Sluiter WJ, Dallinga-Thie GM, van Tol A, Dullaart RP. Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus. Clinical Laboratory. 58: 1231-9. PMID 23289194 |
0.506 |
|
| 2013 |
Kwakernaak AJ, Lambert G, Muller Kobold AC, Dullaart RP. Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects. Thyroid : Official Journal of the American Thyroid Association. 23: 166-72. PMID 23106476 DOI: 10.1089/thy.2012.0434 |
0.383 |
|
| 2012 |
Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. Journal of Clinical Lipidology. 7: 56-64. PMID 23351584 DOI: 10.1016/j.jacl.2012.05.003 |
0.464 |
|
| 2012 |
Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis G, Dullaart RP. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 226: 459-65. PMID 23261172 DOI: 10.1016/j.atherosclerosis.2012.11.009 |
0.366 |
|
| 2012 |
van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FL, Dullaart RP, Kluin-Nelemans HC, Veeger NJ, Meijer K. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study. Thrombosis and Haemostasis. 108: 923-9. PMID 22955992 DOI: 10.1160/TH12-06-0426 |
0.416 |
|
| 2012 |
Constantinides A, de Vries R, van Leeuwen JJ, Gautier T, van Pelt LJ, Tselepis AD, Lagrost L, Dullaart RP. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity. European Journal of Internal Medicine. 23: 633-8. PMID 22902096 DOI: 10.1016/j.ejim.2012.05.008 |
0.38 |
|
| 2012 |
Kappelle PJ, Dullaart RP, van Beek AP, Hillege HL, Wolffenbuttel BH. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study. European Journal of Internal Medicine. 23: 755-9. PMID 22819464 DOI: 10.1016/j.ejim.2012.06.013 |
0.336 |
|
| 2012 |
Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, ... ... Dullaart RP, et al. Lipid-related markers and cardiovascular disease prediction. Jama. 307: 2499-506. PMID 22797450 DOI: 10.1001/Jama.2012.6571 |
0.304 |
|
| 2012 |
Corsetti JP, Bakker SJ, Sparks CE, Dullaart RP. Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein. Plos One. 7: e39110. PMID 22723940 DOI: 10.1371/journal.pone.0039110 |
0.35 |
|
| 2012 |
Dullaart RP, Annema W, de Boer JF, Tietge UJ. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus. Atherosclerosis. 222: 567-73. PMID 22541874 DOI: 10.1016/j.atherosclerosis.2012.03.037 |
0.368 |
|
| 2012 |
Constantinides A, Kappelle PJ, Lambert G, Dullaart RP. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9. Archives of Medical Research. 43: 11-4. PMID 22300679 DOI: 10.1016/j.arcmed.2012.01.001 |
0.387 |
|
| 2012 |
Corsetti JP, Gansevoort RT, Bakker SJ, Navis G, Sparks CE, Dullaart RP. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism: Clinical and Experimental. 61: 996-1002. PMID 22225956 DOI: 10.1016/j.metabol.2011.11.010 |
0.376 |
|
| 2012 |
Kappelle PJ, de Boer JF, Perton FG, Annema W, de Vries R, Dullaart RP, Tietge UJ. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL. European Journal of Clinical Investigation. 42: 487-95. PMID 21955281 DOI: 10.1111/j.1365-2362.2011.02604.x |
0.408 |
|
| 2011 |
de Vries R, Perton FG, van Tol A, Dullaart RP. Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 473-7. PMID 22100832 DOI: 10.1016/j.cca.2011.11.001 |
0.446 |
|
| 2011 |
Mulder DJ, de Boer JF, Graaff R, de Vries R, Annema W, Lefrandt JD, Smit AJ, Tietge UJ, Dullaart RP. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis. 218: 102-6. PMID 21665206 DOI: 10.1016/j.atherosclerosis.2011.05.011 |
0.304 |
|
| 2011 |
Kappelle PJ, Perton F, Hillege HL, Dallinga-Thie GM, Dullaart RP. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study. Atherosclerosis. 217: 249-52. PMID 21524747 DOI: 10.1016/j.atherosclerosis.2011.03.020 |
0.317 |
|
| 2011 |
de Vries R, Groen AK, Dullaart RP. Cholesterol efflux capacity and atherosclerosis. The New England Journal of Medicine. 364: 1473-4; author reply. PMID 21488781 DOI: 10.1056/NEJMc1101853 |
0.41 |
|
| 2011 |
Dullaart RP, Constantinides A, Perton FG, van Leeuwen JJ, van Pelt JL, de Vries R, van Tol A. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile. The Journal of Clinical Endocrinology and Metabolism. 96: 1077-84. PMID 21252249 DOI: 10.1210/jc.2010-2139 |
0.404 |
|
| 2010 |
Corsetti JP, Gansevoort RT, Navis G, Sparks CE, Dullaart RP. LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP. Atherosclerosis. 214: 373-6. PMID 21146168 DOI: 10.1016/j.atherosclerosis.2010.11.029 |
0.331 |
|
| 2010 |
Kappelle PJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients. Atherosclerosis. 214: 432-5. PMID 21122860 DOI: 10.1016/j.atherosclerosis.2010.10.028 |
0.382 |
|
| 2010 |
Kappelle PJ, Ahnström J, Dikkeschei BD, de Vries R, Sluiter WJ, Wolffenbuttel BH, van Tol A, Nielsen LB, Dahlbäck B, Dullaart RP. Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus. Atherosclerosis. 213: 247-50. PMID 20828695 DOI: 10.1016/J.Atherosclerosis.2010.07.048 |
0.372 |
|
| 2010 |
Kappelle PJ, van Tol A, Wolffenbuttel BH, Dullaart RP. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion. Cardiovascular Therapeutics. 29: e89-99. PMID 20645987 DOI: 10.1111/j.1755-5922.2010.00201.x |
0.43 |
|
| 2010 |
Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JC, Jukema JW, ... ... Dullaart RP, et al. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation. 122: 470-7. PMID 20644014 DOI: 10.1161/Circulationaha.109.912519 |
0.375 |
|
| 2010 |
Dullaart RP. Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1502-3. PMID 20631348 DOI: 10.1161/ATVBAHA.110.209544 |
0.338 |
|
| 2010 |
Corsetti JP, Gansevoort RT, Sparks CE, Dullaart RP. Inflammation reduces HDL protection against primary cardiac risk. European Journal of Clinical Investigation. 40: 483-9. PMID 20412290 DOI: 10.1111/j.1365-2362.2010.02287.x |
0.351 |
|
| 2010 |
Krikken JA, Gansevoort RT, Dullaart RP. Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. Journal of Lipid Research. 51: 1982-90. PMID 20211930 DOI: 10.1194/jlr.M005348 |
0.301 |
|
| 2009 |
Dullaart RP, van den Berg G, van der Knaap AM, Dijck-Brouwer J, Dallinga-Thie GM, Zelissen PM, Sluiter WJ, van Beek AP. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment. European Journal of Endocrinology. 162: 227-34. PMID 19926784 DOI: 10.1530/EJE-09-0742 |
0.448 |
|
| 2009 |
Kappelle PJ, Dallinga-Thie GM, Dullaart RP. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. Biochimica Et Biophysica Acta. 1801: 89-94. PMID 19800983 DOI: 10.1016/j.bbalip.2009.09.021 |
0.463 |
|
| 2009 |
Dullaart RP, Perton F, van der Klauw MM, Hillege HL, Sluiter WJ. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol. Atherosclerosis. 208: 537-42. PMID 19698944 DOI: 10.1016/j.atherosclerosis.2009.07.042 |
0.444 |
|
| 2009 |
Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Expert Opinion On Therapeutic Targets. 13: 743-51. PMID 19505224 DOI: 10.1517/14728220903023866 |
0.49 |
|
| 2009 |
Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clinical Endocrinology. 70: 221-6. PMID 18505467 DOI: 10.1111/j.1365-2265.2008.03306.x |
0.364 |
|
| 2008 |
Dullaart RP, Perton F, Sluiter WJ, de Vries R, van Tol A. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. The Journal of Clinical Endocrinology and Metabolism. 93: 4860-6. PMID 18782872 DOI: 10.1210/jc.2008-1213 |
0.431 |
|
| 2008 |
Dullaart RP, Sluiter WJ. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics. 9: 747-63. PMID 18518852 DOI: 10.2217/14622416.9.6.747 |
0.319 |
|
| 2008 |
Dallinga-Thie GM, Dullaart RP, van Tol A. Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development. Current Diabetes Reports. 8: 65-70. PMID 18367001 DOI: 10.1007/s11892-008-0012-3 |
0.527 |
|
| 2008 |
Dullaart RP, Schols JL, van der Steege G, Zelissen PM, Sluiter WJ, van Beek AP. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. Clinical Endocrinology. 69: 359-66. PMID 18221399 DOI: 10.1111/j.1365-2265.2008.03196.x |
0.422 |
|
| 2008 |
Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol. European Journal of Endocrinology. 158: 53-60. PMID 18166817 DOI: 10.1530/EJE-07-0451 |
0.439 |
|
| 2007 |
Dullaart RP, Dallinga-Thie GM, van Tol A. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clinical Endocrinology. 67: 316-7; author reply . PMID 17524037 DOI: 10.1111/j.1365-2265.2007.02866.x |
0.322 |
|
| 2007 |
Dallinga-Thie GM, Dullaart RP, van Tol A. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins. Current Opinion in Lipidology. 18: 251-7. PMID 17495597 DOI: 10.1097/MOL.0b013e3280e12685 |
0.514 |
|
| 2007 |
Borggreve SE, Hillege HL, Dallinga-Thie GM, de Jong PE, Wolffenbuttel BH, Grobbee DE, van Tol A, Dullaart RP. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides. European Heart Journal. 28: 1012-8. PMID 17409111 DOI: 10.1093/eurheartj/ehm062 |
0.33 |
|
| 2006 |
Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. The Journal of Clinical Endocrinology and Metabolism. 91: 3382-8. PMID 16684835 DOI: 10.1210/jc.2005-2322 |
0.445 |
|
| 2006 |
de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, Dullaart RP. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes. 54: 3554-9. PMID 16306375 DOI: 10.2337/diabetes.54.12.3554 |
0.376 |
|
| 2005 |
Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 101-6. PMID 16141462 DOI: 10.1093/ndt/gfi068 |
0.448 |
|
| 2005 |
De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clinical Laboratory. 51: 403-9. PMID 16122151 |
0.347 |
|
| 2005 |
Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. The Journal of Clinical Endocrinology and Metabolism. 90: 4198-204. PMID 15840744 DOI: 10.1210/jc.2005-0182 |
0.398 |
|
| 2004 |
de Vries R, Borggreve SE, Dullaart RP. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. Clinical Laboratory. 49: 601-13. PMID 14651331 |
0.527 |
|
| 2000 |
De Graaf JS, Dullaart RP, Kok T, Piers DA, Zwierstra RP. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. The European Journal of Surgery = Acta Chirurgica. 166: 289-92. PMID 10817323 DOI: 10.1080/110241500750009104 |
0.683 |
|
| 1999 |
de Graaf JS, Dullaart RP, Zwierstra RP. Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2--a plea to conserve adrenal function. The European Journal of Surgery = Acta Chirurgica. 165: 843-6. PMID 10533758 DOI: 10.1080/11024159950189320 |
0.702 |
|
| 1997 |
Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes. 46: 2082-7. PMID 9392500 DOI: 10.2337/diab.46.12.2082 |
0.804 |
|
| 1991 |
Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H. Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care. 14: 338-41. PMID 2060438 DOI: 10.2337/diacare.14.4.338 |
0.736 |
|
| 1990 |
Dullaart RP, Hoogenberg K, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: a possible contribution to alterations in high-density lipoproteins. European Journal of Clinical Investigation. 20: 581-7. PMID 2127747 DOI: 10.1111/j.1365-2362.1990.tb01904.x |
0.746 |
|
| 1989 |
Dullaart RP, Groener JE, van Wijk H, Sluiter WJ, Erkelens DW. Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men. Arteriosclerosis (Dallas, Tex.). 9: 614-22. PMID 2783075 DOI: 10.1161/01.atv.9.5.614 |
0.766 |
|
| 1989 |
Dullaart RP, Groener JE, Dikkeschei LD, Erkelens DW, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids. Diabetologia. 32: 14-9. PMID 2707515 DOI: 10.1007/BF00265398 |
0.736 |
|
| 1988 |
Erkelens DW, Dullaart RP. In vivo evidence for cholesterol ester and triglyceride exchange between high density lipoprotein and infused triglyceride rich particles in abetalipoproteinemia. Advances in Experimental Medicine and Biology. 243: 247-53. PMID 3223418 DOI: 10.1007/978-1-4613-0733-4_31 |
0.781 |
|
| 1987 |
Dullaart RP, Groener JE, Erkelens DW. Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro. European Journal of Clinical Investigation. 17: 241-8. PMID 3113969 DOI: 10.1111/j.1365-2362.1987.tb01243.x |
0.751 |
|
| Show low-probability matches. |